| ERSGX | NRGEX | ERSGX / NRGEX | |
| Total Expense Ratio | 1.46 | 0.03 | 4,867% |
| Annual Report Gross Expense Ratio | 1.61 | 0.69 | 233% |
| Fund Existence | 16 years | 4 years | - |
| Gain YTD | -6.454 | -3.571 | 181% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 155M | 8.43B | 2% |
| Annual Yield % from dividends | 0.10 | 0.55 | 18% |
| Returns for 1 year | -13.68 | -13.32 | 103% |
| Returns for 3 years | 5.82 | 0.35 | 1,665% |
| Returns for 5 years | 5.73 | N/A | - |
| Returns for 10 years | -1.74 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 26.26 | 0.06 | +0.23% |
| Saratoga Health & Biotechnology I | |||
| SVBCX | 32.47 | 0.05 | +0.15% |
| JHancock Balanced C | |||
| SCUIX | 32.23 | 0.02 | +0.06% |
| Hartford Schroders US Small Cap Opps I | |||
| HRCUX | 72.37 | 0.03 | +0.04% |
| Carillon ClariVest Capital Apprec R6 | |||
| TMDIX | 19.24 | -0.02 | -0.10% |
| AMG TimesSquare Mid Cap Growth Z | |||